187 related articles for article (PubMed ID: 33352292)
1. Clinical and Economic Burden of Glaucoma by Disease Severity: A United States Claims-Based Analysis.
Shih V; Parekh M; Multani JK; McGuiness CB; Chen CC; Campbell JH; Miller-Ellis E; Olivier MMG
Ophthalmol Glaucoma; 2021; 4(5):490-503. PubMed ID: 33352292
[TBL] [Abstract][Full Text] [Related]
2. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
[TBL] [Abstract][Full Text] [Related]
3. Four-year incidence of open-angle glaucoma and ocular hypertension: the Los Angeles Latino Eye Study.
Varma R; Wang D; Wu C; Francis BA; Nguyen BB; Chopra V; Memarzadeh F; Torres M; Azen SP;
Am J Ophthalmol; 2012 Aug; 154(2):315-325.e1. PubMed ID: 22541649
[TBL] [Abstract][Full Text] [Related]
4. Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial.
Garg A; Vickerstaff V; Nathwani N; Garway-Heath D; Konstantakopoulou E; Ambler G; Bunce C; Wormald R; Barton K; Gazzard G;
Ophthalmology; 2019 Sep; 126(9):1238-1248. PubMed ID: 31028768
[TBL] [Abstract][Full Text] [Related]
5. Sociodemographic, family history, and lifestyle risk factors for open-angle glaucoma and ocular hypertension. The Los Angeles Latino Eye Study.
Doshi V; Ying-Lai M; Azen SP; Varma R;
Ophthalmology; 2008 Apr; 115(4):639-647.e2. PubMed ID: 17900693
[TBL] [Abstract][Full Text] [Related]
6. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany.
Lorenz K; Wolfram C; Breitscheidel L; Shlaen M; Verboven Y; Pfeiffer N
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2019-28. PubMed ID: 23624617
[TBL] [Abstract][Full Text] [Related]
7. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study.
Varma R; Ying-Lai M; Francis BA; Nguyen BB; Deneen J; Wilson MR; Azen SP;
Ophthalmology; 2004 Aug; 111(8):1439-48. PubMed ID: 15288969
[TBL] [Abstract][Full Text] [Related]
9. The Frequency of Visual Field Testing in a US Nationwide Cohort of Individuals with Open-Angle Glaucoma.
Stagg BC; Stein JD; Medeiros FA; Horns J; Hartnett ME; Kawamoto K; Hess R
Ophthalmol Glaucoma; 2022; 5(6):587-593. PubMed ID: 35605937
[TBL] [Abstract][Full Text] [Related]
10. Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization.
Trese MGJ; Lewis AW; Blachley TS; Stein JD; Moroi SE
J Ocul Pharmacol Ther; 2017 Oct; 33(8):591-597. PubMed ID: 28854348
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD; Katz LJ; Mills RP; Myers JS; Noecker RJ; Piltz-Seymour JR; Ritch RR; Schacknow PN; Serle JB; Trick GL
Arch Ophthalmol; 2006 Jan; 124(1):12-9. PubMed ID: 16401779
[TBL] [Abstract][Full Text] [Related]
12. TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA.
Vié AL; Kodjikian L; Malclès A; Agard E; Voirin N; El Chehab H; Nguyen AM; Dot C
Retina; 2017 Jan; 37(1):173-178. PubMed ID: 27465569
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Treatment Patterns of Newly Diagnosed Open-Angle Glaucoma Patients in the United States: An Administrative Database Analysis.
Schwartz GF; Patel A; Naik R; Lunacsek O; Ogbonnaya A; Campbell J
Ophthalmol Glaucoma; 2021; 4(2):117-125. PubMed ID: 32927109
[TBL] [Abstract][Full Text] [Related]
14. Baseline risk factors that predict the development of open-angle glaucoma in a population: the Los Angeles Latino Eye Study.
Jiang X; Varma R; Wu S; Torres M; Azen SP; Francis BA; Chopra V; Nguyen BB;
Ophthalmology; 2012 Nov; 119(11):2245-53. PubMed ID: 22796305
[TBL] [Abstract][Full Text] [Related]
15. SHORT TERM EVALUATION OF PERIMETRIC PROGRESSION IN PATIENTS WITH OPEN ANGLE GLAUCOMA AND DIABETES.
Pantalon A; Feraru C; Chiseliţa D
Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):83-9. PubMed ID: 27125077
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Ocular Hypertension and Glaucoma as Well as Associated Factors in Graves' Orbitopathy.
Kim JW; Ko J; Woo YJ; Bae HW; Yoon JS
J Glaucoma; 2018 May; 27(5):464-469. PubMed ID: 29557835
[TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation.
Burr JM; Mowatt G; Hernández R; Siddiqui MA; Cook J; Lourenco T; Ramsay C; Vale L; Fraser C; Azuara-Blanco A; Deeks J; Cairns J; Wormald R; McPherson S; Rabindranath K; Grant A
Health Technol Assess; 2007 Oct; 11(41):iii-iv, ix-x, 1-190. PubMed ID: 17927922
[TBL] [Abstract][Full Text] [Related]
18. Incremental Healthcare Service Utilization for Open-angle Glaucoma: A Population-Based Study.
Chung SD; Ho JD; Lin HC; Kao LT; Tsai MC
J Glaucoma; 2015; 24(5):e116-20. PubMed ID: 25642815
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic Disparities in Glaucoma Severity at Initial Diagnosis: A Nationwide Electronic Health Record Cohort Analysis.
Swaminathan SS; Medeiros FA
Am J Ophthalmol; 2024 Jul; 263():50-60. PubMed ID: 38395325
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of first- or second-line latanoprost on intraocular pressure and ocular symptoms in patients with open-angle glaucoma or ocular hypertension].
Baudouin C; Rouland JF; Nordmann JP; Bron A; Pelen F
J Fr Ophtalmol; 2006 Jun; 29(6):615-24. PubMed ID: 16885890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
